Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ferraris Medical recalls apnoea respiration monitors:

This article was originally published in Clinica

Executive Summary

Ferraris Medical has recalled 700 units of its Eastleigh RE200 and RE200C apnoea respiration monitors after a unit failed to alarm, according to a device alert issued yesterday (October 20 2003) by the Medicines and Healthcare products Regulatory Agency (MHRA). These devices, used to monitor the breathing of premature babies and patients at risk of apnoea, have been fitted since 1991 with an alarm delay switch. An incorrect type of switch was used in some of the units, which disables the alarm if positioned between delay settings, the Hertford, UK company reports. The affected devices, previously manufactured by (and in some cases still labelled) NH Eastwood and Son, will be refurbished by installing an alarm test at the affected setting.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT063998

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel